Average Co-Inventor Count = 4.95
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (2 from 832,812 patents)
9 patents:
1. 12225906 - Pathogenic affinity pathway of infectious or parasitic organisms for nanogram and picogram dosimetry prophylaxis or cure
2. 12220468 - Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis
3. 12005132 - Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis
4. 12005077 - Broad-spectrum antimicrobial, biocompatible and preservative-free functionalized fullerenes ophthalmic solution with reactive oxygen species scavenging and advanced targeting, penetration, and hydration
5. 11872109 - Customized ear compression device for keloid management
6. 11813363 - Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
7. 11771125 - Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
8. 11653984 - Unassisted robotic surgery employing paramagnetic halo metallofullerenes as minimally invasive, precision scalpels or micronization particles through magnetic field manipulation and targeted exenteration patterned by programmed 3D imaging using needle or magnetic energy access and microelectronic semiconducting in non-stationary wafer-less space
9. 11638720 - Risk mitigation of infectious disease transmission from incidental and intimate contact using atomic scale molecular disruption and biocidal halo-fullerenes delivered via topical, flushing and enteral mechanisms